SHANNON MESTER: Open Payments
NPI 1093290017 · MUNFORDVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 25 payments from 14 companies in 2025. Trend: 2023 $138 · 2024 $681 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $103 |
| GlaxoSmithKline, LLC. | 5 | $74 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Corium, LLC | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Cipher Pharmaceuticals US LLC | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| Amgen Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
Products named: CAPLYTA, TRELEGY ELLIPTA, REXULTI, Azstarys, FANAPT, Natroba, Rybelsus, OTEZLA.
Industry payments across KY — which companies pay providers there.
